Community-Empowerment and Environmental Enrichment-based Co-management (CEEEC) Model and Mechanisms for Improving Health of Older Stroke Patients With Multimorbidity

NCT ID: NCT06975501

Last Updated: 2025-05-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

444 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-06-20

Study Completion Date

2027-06-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is a cluster randomized controlled trial with a 2×2 factorial design conducted in community health centers in Kunshan, Harbin, Wuhan and Shanghai. It aims to evaluate the independent and combined effects of exercise and cognitive interventions on intrinsic capacity and related health outcomes among stroke survivors aged 60 years and older with hypertension or type 2 diabetes mellitus. Participants will receive either exercise training, cognitive training, combined training, or usual care over 12 months, followed by a 12-month follow-up. Findings will inform integrated health management strategies for older adults with multimorbidity.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is a community-based cluster randomized controlled trial with a 2×2 factorial design, conducted in community health centers in Kunshan (Jiangsu), Wuhan (Hubei), Harbin (Heilongjiang), and Shanghai, China. A total of 480 stroke survivors aged 60 years and above with comorbid hypertension or type 2 diabetes mellitus will be recruited. Participants will be randomly assigned to one of four groups: exercise intervention only, cognitive intervention only, combined intervention, or control (usual care). The interventions, including aerobic-balance physical training and structured cognitive training, will be delivered twice weekly for 12 months, followed by a 12-month observational follow-up.

The primary outcome is intrinsic capacity (IC), assessed using the World Health Organization Integrated Care for Older People (WHO ICOPE) framework. Secondary outcomes include systolic blood pressure, quality of life (EuroQol 5-Dimension 5-Level, EQ-5D-5L), medication adherence, physical activity (Metabolic Equivalent of Task minutes per week, MET-min/week), and healthcare utilization. Data will be collected at baseline, 6, 12, and 24 months.

Intervention effects and trajectories over time will be analyzed using two-way analysis of variance (ANOVA), repeated measures ANOVA, and mixed-effects models. Implementation outcomes will be evaluated following the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework. The study aims to generate evidence for integrated health management strategies for older adults with stroke and multimorbidity in urban China.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertension Type 2 Diabetes Mellitus (T2DM) Multimorbidity Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Active Control

Participants in this arm will receive medication compliance education from the family doctor.

Group Type NO_INTERVENTION

No interventions assigned to this group

Physical Activity Only

Participants will receive twice-weekly aerobic and balance training sessions, with medication compliance education.

Group Type EXPERIMENTAL

Exercise Intervention

Intervention Type BEHAVIORAL

Participants will receive twice-weekly aerobic and balance training sessions, with medication compliance education.

Cognitive Training Only

Participants in this arm will participate in twice-weekly structured cognitive training sessions, with medication compliance education.

Group Type EXPERIMENTAL

Cognitive Intervention

Intervention Type BEHAVIORAL

Participants will participate in twice-weekly structured cognitive training sessions, with medication compliance education.

Combined Physical + Cognitive

Participants in this arm will receive both twice-weekly aerobic and balance training sessions and twice-weekly structured cognitive training sessions, with medication compliance education.

Group Type EXPERIMENTAL

Exercise Intervention

Intervention Type BEHAVIORAL

Participants will receive twice-weekly aerobic and balance training sessions, with medication compliance education.

Cognitive Intervention

Intervention Type BEHAVIORAL

Participants will participate in twice-weekly structured cognitive training sessions, with medication compliance education.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Exercise Intervention

Participants will receive twice-weekly aerobic and balance training sessions, with medication compliance education.

Intervention Type BEHAVIORAL

Cognitive Intervention

Participants will participate in twice-weekly structured cognitive training sessions, with medication compliance education.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged ≥60 years
* The doctor diagnosed it as a stroke and it is in a stable stage (the diagnosis time is not limited)
* Patients with concurrent hypertension and/or diabetes may also have other diseases at the same time
* Be able to participate in a community intervention lasting for six months
* Be informed and agree to participate in the research

Exclusion Criteria

* With the aid of a walking aid (not a wheelchair), it is also impossible to walk independently to the community service center.
* Lack basic communication skills and do not recognize Arabic numerals
* Suffering from life-threatening diseases, with a survival expectation of less than 6 months, etc.
Minimum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Wuhan University

OTHER

Sponsor Role collaborator

Harbin Medical University

OTHER

Sponsor Role collaborator

Shanghai Jiao Tong University School of Medicine

OTHER

Sponsor Role collaborator

Duke Kunshan University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Lijing Yan

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Duke Kunshan University

Suzhou, Jiangsu, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Bolu Yang, PhD Candidate

Role: CONTACT

86-17798560877

Lijing Yan, Professor

Role: CONTACT

86-51236657057

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Lijing Yan, Professor

Role: primary

86-51236657057

References

Explore related publications, articles, or registry entries linked to this study.

Ni Z, Atluri N, Shaw RJ, Tan J, Khan K, Merk H, Ge Y, Shrestha S, Shrestha A, Vasudevan L, Karmacharya B, Yan LL. Correction: Evaluating the Feasibility and Acceptability of a Mobile Health-Based Female Community Health Volunteer Program for Hypertension Control in Rural Nepal: Cross-Sectional Study. JMIR Mhealth Uhealth. 2020 Jun 11;8(6):e19048. doi: 10.2196/19048.

Reference Type BACKGROUND
PMID: 32525811 (View on PubMed)

Gong E, Lu H, Shao S, Tao X, Peoples N, Kohrt BA, Xiong S, Kyobutungi C, Haregu TN, Khayeka-Wandabwa C, Van Minh H, Hanh TTD, Koirala S, Gautam K, Yan LL. Feasibility assessment of invigorating grassrooTs primary healthcare for prevention and management of cardiometabolic diseases in resource-limited settings in China, Kenya, Nepal, Vietnam (the FAITH study): rationale and design. Glob Health Res Policy. 2019 Nov 12;4:33. doi: 10.1186/s41256-019-0124-0. eCollection 2019.

Reference Type BACKGROUND
PMID: 31742234 (View on PubMed)

Yan LL, Gong E, Gu W, Turner EL, Gallis JA, Zhou Y, Li Z, McCormack KE, Xu LQ, Bettger JP, Tang S, Wang Y, Oldenburg B. Effectiveness of a primary care-based integrated mobile health intervention for stroke management in rural China (SINEMA): A cluster-randomized controlled trial. PLoS Med. 2021 Apr 28;18(4):e1003582. doi: 10.1371/journal.pmed.1003582. eCollection 2021 Apr.

Reference Type BACKGROUND
PMID: 33909607 (View on PubMed)

Tian M, Ajay VS, Dunzhu D, Hameed SS, Li X, Liu Z, Li C, Chen H, Cho K, Li R, Zhao X, Jindal D, Rawal I, Ali MK, Peterson ED, Ji J, Amarchand R, Krishnan A, Tandon N, Xu LQ, Wu Y, Prabhakaran D, Yan LL. A Cluster-Randomized, Controlled Trial of a Simplified Multifaceted Management Program for Individuals at High Cardiovascular Risk (SimCard Trial) in Rural Tibet, China, and Haryana, India. Circulation. 2015 Sep 1;132(9):815-24. doi: 10.1161/CIRCULATIONAHA.115.015373. Epub 2015 Jul 17.

Reference Type BACKGROUND
PMID: 26187183 (View on PubMed)

Yan LL, Fang W, Delong E, Neal B, Peterson ED, Huang Y, Sun N, Yao C, Li X, MacMahon S, Wu Y. Population impact of a high cardiovascular risk management program delivered by village doctors in rural China: design and rationale of a large, cluster-randomized controlled trial. BMC Public Health. 2014 Apr 11;14:345. doi: 10.1186/1471-2458-14-345.

Reference Type BACKGROUND
PMID: 24721435 (View on PubMed)

Zhu G, Malhotra R, Xiong S, Chen X, Zhang M, Wu Y, Gong E, Wang Z, Tian X, Peng W, Ostbye T, Yan LL. Community Efficacy for Non-Communicable Disease Management and Medication Adherence: The Sequential Mediating Role of Self-Efficacy and Depressive Symptoms. Patient Prefer Adherence. 2023 Dec 14;17:3421-3433. doi: 10.2147/PPA.S436419. eCollection 2023.

Reference Type BACKGROUND
PMID: 38111691 (View on PubMed)

Xiong S, Zhu G, Malhotra R, Chen X, Gong E, Wang Z, Zhang J, Peng W, Wang S, Jin X, Peoples N, Ostbye T, Tian M, Yan LL. Community efficacy for non-communicable disease management (COEN): Conceptualization and measurement. PLOS Glob Public Health. 2024 Aug 14;4(8):e0003549. doi: 10.1371/journal.pgph.0003549. eCollection 2024.

Reference Type BACKGROUND
PMID: 39141640 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2025DKU

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Strength Training and Stroke
NCT00629005 COMPLETED PHASE1/PHASE2